Amnion Patch Market Report 2026
Global Outlook – By Product Type (Transplantation Grade Amnion Patches, Transplantation Grade Amnion Or Chorion Patches, Suspension Liquid Amnio Patch), By Application (Corneal Repair, Ocular Surface Reconstruction, Amniotic Membrane Transplantation, Dental Applications, Wound Healing, Orthopedic Applications), By End User (Hospitals, Eye Banks, Clinics, Research Institutes) – Market Size, Trends, Strategies, and Forecast to 2030
Amnion Patch Market Overview
• Amnion Patch market size has reached to $1.91 billion in 2025 • Expected to grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Rise In Diabetes Prevalence Fueling The Growth Of The Market Due To Increasing Need For Advanced Wound-Healing Solutions • Market Trend: Advancements In Dual-Layer Amniotic Membrane Innovations Enhancing Biological Wound Healing • North America was the largest region in 2025.What Is Covered Under Amnion Patch Market?
An amnion patch is a medical device derived from the amniotic membrane, often used in surgical procedures and wound care. It leverages the natural properties of the amniotic membrane, such as anti-inflammatory and regenerative factors, to promote healing and tissue repair. The patch is typically applied to wounds or surgical sites to enhance recovery, reduce scarring, and support tissue regeneration. The main product types of amnion patches are transplantation-grade amnion patches, transplantation-grade amnion or chorion patches, and suspension liquid amnio patches. Transplantation-grade amnion patches are high-quality amniotic membrane patches specifically prepared for use in medical transplant procedures. The applications are corneal repair, ocular surface reconstruction, amniotic membrane transplantation, dental applications, wound healing, and orthopedic applications, and they are used by various end-users such as hospitals, eye banks, clinics, and research institutes.
What Is The Amnion Patch Market Size and Share 2026?
The amnion patch market size has grown strongly in recent years. It will grow from $1.91 billion in 2025 to $2.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to limited availability of amniotic membrane products, reliance on fresh tissue grafts, growing demand for ocular surface reconstruction, increasing hospital and clinic procedures, lack of standardized preservation techniques.What Is The Amnion Patch Market Growth Forecast?
The amnion patch market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of cryopreserved and lyophilized amnion patches, rising adoption in corneal repair and ocular surgeries, growth in dental and orthopedic applications, increasing research and development initiatives, expansion of eye banks and tissue banks. Major trends in the forecast period include rising use of amnion patches in wound healing and tissue regeneration, increased adoption of cryopreserved and lyophilized products, expansion of ophthalmic and dental applications, growing focus on minimally invasive surgical procedures, enhanced regulatory compliance and quality standards for amniotic products.
Global Amnion Patch Market Segmentation
1) By Product Type: Transplantation Grade Amnion Patches, Transplantation Grade Amnion Or Chorion Patches, Suspension Liquid Amnio Patch 2) By Application: Corneal Repair, Ocular Surface Reconstruction, Amniotic Membrane Transplantation, Dental Applications, Wound Healing, Orthopedic Applications 3) By End User: Hospitals, Eye Banks, Clinics, Research Institutes Subsegments: 1) By Transplantation Grade Amnion Patches: Cryopreserved Transplantation Grade Amnion Patches, Lyophilized Transplantation Grade Amnion Patches, Fresh Transplantation Grade Amnion Patches 2) By Transplantation Grade Amnion or Chorion Patches: Cryopreserved Amnion or Chorion Patches, Lyophilized Amnion or Chorion Patches, Fresh Amnion Or Chorion Patches 3) By Suspension Liquid Amnio Patch: Cryopreserved Suspension Liquid Amnio Patch, Lyophilized Suspension Liquid Amnio Patch, Fresh Suspension Liquid Amnio PatchWhat Is The Driver Of The Amnion Patch Market?
The increase in prevalence of diabetes is expected to drive the growth of the amnion patch market going forward. The increasing prevalence of diabetes is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition. Amnion patches are used in diabetic foot ulcers caused by severe diabetes to promote faster healing by providing bioactive tissue that supports cell regeneration and reduces inflammation. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increase in prevalence of diabetes is driving the growth of the amnion patch industry.Key Players In The Global Amnion Patch Market
Major companies operating in the amnion patch market are Integra LifeSciences Corporation, AlloSource, Bio‑Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Celularity, Royal Biologics, NuVision Biotherapies Ltd, Olifant Biologics, MTF Biologics, BioHealing, MiMedx Group Inc, Amnio Technology LLC, Amniox Medical Inc, Regenative Labs LLC, Organogenesis Inc, Skye Biologics Holdings LLC, Human Regenerative Technologies LLC, Genesis Biologics, Ventris Medical LLC
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Amnion Patch Market Trends and Insights
Major companies operating in the amnion patch market are focusing on developing innovative products, such as dehydrated dual‑layer amniotic membrane patches, to provide a shelf‑stable, biologically active scaffold that supports wound healing and protects tissue. A dehydrated dual‑layer amniotic membrane patch is a two‑layer allograft derived from placental tissue, processed to preserve extracellular matrix components, that acts as both a barrier and a scaffold, while being stable at room temperature. For instance, in 2025, Mindsight Medical / Total Ancillary, a US-based provider of biologic wound care grafts, launched the RevoShield+ Dual Layer Amnio Patch. This patch is made from dehydrated human amniotic membrane, offers a five‑year shelf life at room temperature, and can be applied easily with or without glue or sutures. It limits moisture loss, acts as a protective barrier, and serves as a biological scaffold for tissue reconstruction in acute and chronic wounds, podiatry, Mohs surgery, and more.What Are Latest Mergers And Acquisitions In The Amnion Patch Market?
In September 2023, Globus Medical, Inc., a US-based medical device company, merged with NuVasive to form a leading global entity that advances spine and orthopedic care through extensive procedural solutions and technologies. This merger combines their complementary global scale, expanded commercial reach, comprehensive portfolios, and commitment to product development, surgeon education, and enhanced operational capabilities. NuVasive Inc. is a US-based medical device company.
Regional Outlook
North America was the largest region in the amnion patch market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Amnion Patch Market?
The amnion patch market consists of sales of amniotic fluid injections, amnion patch dressings, and amniotic membrane grafts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Amnion Patch Market Report 2026?
The amnion patch market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the amnion patch industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Amnion Patch Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.07 billion |
| Revenue Forecast In 2030 | $2.81 billion |
| Growth Rate | CAGR of 8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Integra LifeSciences Corporation, AlloSource, Bio‑Tissue Inc., Infinity Biologics Inc., VIVEX Biologics Inc., Tissue Regenix Ltd, Celularity, Royal Biologics, NuVision Biotherapies Ltd, Olifant Biologics, MTF Biologics, BioHealing, MiMedx Group Inc, Amnio Technology LLC, Amniox Medical Inc, Regenative Labs LLC, Organogenesis Inc, Skye Biologics Holdings LLC, Human Regenerative Technologies LLC, Genesis Biologics, Ventris Medical LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |